The Patient-Centered Outcomes Research Institute (PCORI) intends to issue the Addressing Sensory Health Needs Across the Lifespan PCORI Funding Announcement (PFA) on April 1, 2026, seeking to fund high-impact, patient-centered comparative clinical effectiveness research (CER) projects that focus on advancing care and outcomes across the lifespan for people living with sensory health conditions. Proposed CER projects should inform health decisions for people with sensory disorders, their families and care partners in the United States experiencing high burdens and practice variations in sensory health care and outcomes. This preannouncement provides potential applicants with additional time to identify collaborators; obtain patient and stakeholder input on potential studies; and develop responsive, high-quality applications.
Research Initiative Highlights
Sensory health needs encompass a broad range of conditions that can be present from birth, develop during childhood or adulthood or occur later in life. PCORI’s description of sensory health includes conditions affecting one or more of the body’s sensory systems, such as visual, auditory, olfactory, touch, taste, proprioceptive, vestibular and interoceptive systems. In addition, sensory health conditions can lead to differences in communication, mobility, orientation, balance and accessing information. Moreover, there are variations across the care continuum in access to care, quality of care and outcomes due to factors such as geographic location and income. Significantly, sensory conditions have a wide-ranging impact and have been shown to increase mortality, impair cognitive function, diminish health-related quality of life and lead to poor mental health outcomes. Across the lifespan, individuals at risk of sensory health conditions need increased access to screening for early identification of sensory health conditions; adequate and appropriate access to quality care; effective coordination across various health systems in implementing their care; and access to support services for themselves, their families and their care partners. This topical PFA will solicit applications proposing to address patient-centered CER questions that will fill evidence gaps in the areas of screening, treatment, support services and interventions that address health outcomes associated with sensory conditions.
PCORI is particularly interested in submissions that address the following Special Areas of Emphasis (SAEs). The purpose of identifying these SAEs is to encourage submissions to these areas, rather than limiting submissions to these topics. Applicants addressing one of the below SAEs should identify the area that is best associated with their research approach.
Enhancing support services to improve mental health and address stigma experienced by individuals with sensory health conditions, their families and their care partners: People with sensory conditions such as vision, hearing, smell, touch and taste disorders frequently have associated mental health conditions. Often, individuals with sensory health conditions experience stigmatization from clinicians or family members and through interactions with individuals at work or school. The combination of poorer mental health outcomes such as loneliness, isolation, anxiety or depression, in combination with stigma, often requires a holistic approach to meaningfully improve quality of life for these individuals and their families.
PCORI is interested in studies that address mental-health-based interventions that include education and support services for people with sensory health needs, including those with vision, hearing, balance, touch, taste and vestibular regulation or integration challenges. These may include comparisons of different models of support services for sensory health conditions that incorporate patient-, family- and care-partner-centered outcomes; leverage interdisciplinary teams; and focus on a range of populations impacted by sensory health.
Applicants are strongly encouraged to propose individual- or cluster-randomized controlled trials; however, well-specified natural experiments and well-designed observational studies will also be considered. Proposed studies should be powered with an overall sample size adequate for the precise estimation of hypothesized effect sizes and where appropriate, assessing heterogeneity of treatment effect is strongly encouraged. Applicants are encouraged to pay special attention to issues of intervention implementation with the aim of facilitating widespread uptake of findings and sustainability of the interventions after completion of the study by utilizing hybrid effectiveness-implementation approaches. However, strict implementation or dissemination studies will not be considered responsive, nor will studies that focus on the development of research methods. Applicants should propose well-justified and validated outcomes in the target population that are clinically meaningful and considered important by patients, families and care partners, and that can be impacted by the proposed interventions within the study duration.
In PCORI-funded research, patients and other research partners are expected to meaningfully contribute their lived experience or professional expertise to ensure studies are patient-centered, relevant and useful for healthcare decision making. Applicants must address PCORI’s Foundational Expectations for Partnerships in Research — an evidence-based framework supported by tools and resources to guide effective engagement strategies. Details on each of the Foundational Expectations are available on PCORI’s website. Applicants are also strongly encouraged to consider the inclusion of a broad range of patient-centered burdens and economic outcomes.
Online System Opens
April 1, 2026, 9 am (ET)
Applicant Town Hall
Jan. 22, 2026; 12 - 1 pm (ET)
View Event
Letter of Intent Deadline
April 28, 2026, 5 pm (ET)
Letter of Intent Status Notification
June 2, 2026, 5 pm (ET)
Application Deadline
Sept. 1, 2026, 5 pm (ET)
Merit Review
November 2026
Awards Announced
April 2027 (Subject to Change)
Earliest Start Date
August 2027
Funds Available Up To
$60 million
Budget
Up to $12 million
Maximum Project Period
Up to five years
🧠 1. Clear Patient-Centered Focus
PCORI emphasizes questions and outcomes that matter to patients and caregivers — such as symptom relief, quality of life, care experience, and decision making — rather than exclusively surrogate or laboratory endpoints. PCORI
Tip: Define research questions in terms of patient priorities, not just scientific interest.
🤝 2. Engagement of Patients & Stakeholders
A hallmark of PCORI’s Merit Review is explicit requirements for meaningful involvement of patients, caregivers and other stakeholders during proposal development, design and execution. Engagement is a distinct criterion reviewers consider alongside scientific merit. ScienceDirect
Tip: Build stakeholder engagement plans that demonstrate how patients/communities will influence key decisions (choice of comparators, outcomes, recruitment strategies).
🔍 3. Comparative Effectiveness Design
PCORI requires that studies compare two or more care options relevant to real healthcare decisions — this is central to eligibility. PCORI
Tip: Ensure the comparison (e.g., two treatments, delivery strategies, screening options) reflects real choices patients/clinicians face.
📊 4. Methodological Rigor & Feasibility
Competitive proposals have robust study designs, clear definitions of outcomes and analyses that support valid comparisons, with realistic timelines and scalable recruitment plans. PCORI
Tip: Develop rigorous plans tailored to CER, including statistical methods and pragmatic implementation plans.
📅 5. Alignment With Specific PFA Priorities
Each PFA has defined scope and priorities (e.g., methods for engagement; implementation in health systems). Applications must match the language and goals of the specific funding announcement. PCORI
Tip: Tailor aims to the exact PFA requirements rather than submitting generic CER designs.
📣 6. Dissemination & Uptake Planning
Projects that include clear dissemination and implementation plans — describing how results will be shared with patients, clinicians, health systems, or policymakers — score stronger on relevance and impact. PCORI
Tip: Include strategies for uptake, such as integration into clinical guidelines, digital tools, or decision aids.
📑 7. Organizational Capacity & Collaboration
Because PCORI awards are often larger and multi-site, reviewers value organizational experience in complex CER, including data systems, partnerships with clinical sites or community networks, and multidisciplinary teams. PCORI
Tip: Demonstrate infrastructure for recruitment, data management, and stakeholder engagement.
✔ Start early & follow cycles: PCORI issues repeated funding opportunity cycles (e.g., spring, fall). PCORI
✔ Use PCORI resources: Attend webinars and use application guides and templates provided on the PCORI website. PCORI
✔ Engage stakeholders early: Integrate patient partners before LOI submission to shape the research question. ScienceDirect
✔ Monitor announcements: Subscribe to PCORI emails for updates on new PFAs and registry of funded projects. PCORI
| Success Predictor | Why It Matters |
|---|---|
| Patient-Centered Focus | Core mission of PCORI; shapes review. PCORI |
| Stakeholder Engagement | Engagement is a standalone review criterion. ScienceDirect |
| Comparative Design | Must compare options relevant to patients. PCORI |
| Methodological Quality | Ensures credible, useful conclusions. PCORI |
| Alignment With PFA Scope | Match to solicitation goals. PCORI |
| Dissemination & Implementation Plan | Enhances real-world impact. PCORI |
| Organizational Capacity | Supports execution of complex CER. |
Organizations, not individuals: Eligible applicants include universities, hospitals, research institutes, healthcare systems, nonprofit community groups and similar entities. Individuals may NOT directly apply. PCORI
PCORI requires applicants to use its online submission system (PCORI Online) for Letters of Intent (LOIs) and full applications and to meet published deadlines.
Sponsor Institute/Organizations: Patient-Centered Outcomes Research Institute
Sponsor Type: Corporate/Non-Profit
Address: 1333 New Hampshire Avenue NW, Suite 1200 Washington, DC 20036 Phone: (202) 827-7700 | Fax: (202) 355-9558
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 01, 2026
Sep 01, 2026
$12,000,000
Affiliation: Patient-Centered Outcomes Research Institute
Address: 1333 New Hampshire Avenue NW, Suite 1200 Washington, DC 20036 Phone: (202) 827-7700 | Fax: (202) 355-9558
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.